Because GIP receptor activation affects fat metabolism through pathways separate from appetite control, there is a theoretical basis for better weight maintenance at lower tirzepatide doses compared to equivalent semaglutide doses
Circ Res (2015) 116:11626
Individuals who are overweight or obese with weight-related medical problems, or those who struggle with weight management, may be candidates for Semaglutide, subject to a doctor's approval
People who travel frequently and need a portable option without cold chain requirements
Share your insights and clinical experiences below #Ozempic #Semaglutide #GLP1RA #Type2Diabetes #DiabetesCare #ObesityTreatment #WeightManagement #CardiovascularOutcomes #PharmacyPractice #HospitalPharmacy #CommunityPharmacy #SaudiMOH #HealthcareSaudi #SaudiArabiaHealth #Pharmacist #Physicians #Endocrinology #MetabolicSyndrome #DiabetesGuidelines #PharmacyRecruitment #MedicalRecruitment #LinkedInHealth Updated: March 2024 | Based on latest ADA/EASD, Saudi MOH & International Guidelines
Pham H, Sivaraj D, Sun Y, et al